Evidence map›Paper›PMID 34862941›Full record

ArticleInternational journal of clinical oncology2022

Correction to: COVID‑19 infection in pediatric patients treated for cancer.

Lital Oz-Alcalay, Sarah Elitzur, Nofar Amitai, Helen Toledano, Shlomit Barzilai-Birenboim, Gali Avrahami, Gil Gilad, Yoav Vardi, Michal Dvori, Shai Izraeli and 2 more

Abstract readPublished Erratum
In one paragraph

Article in International journal of clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Lital Oz-AlcalayDepartment A, Hematology-Oncology Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Sarah ElitzurDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Nofar AmitaiDepartment A, Hematology-Oncology Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Helen ToledanoDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Shlomit Barzilai-BirenboimDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Gali AvrahamiDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Gil GiladDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Yoav VardiDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Michal DvoriDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Shai IzraeliDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Gilat LivniDepartment A, Hematology-Oncology Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Oded GiladDepartment of Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel. dkgsguss@gmail.com.ORCID http://orcid.org/0000-0002-0033-3425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34862941
PMCPMC8642742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.